C12N2760/18511 - CPC Classification Index

ClassID:

110976 ⎘

C12N2760/18511 - CPC Classification

Classification description:

ssRNA viruses negative-sense; Details; Paramyxoviridae Pneumovirus, e.g. human respiratory syncytial virus

Sub-classes:

C12N2760/18521 » Viruses as such, e.g. new isolates, mutants or their genomic sequences 32
C12N2760/18522 » New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes 306
C12N2760/18523 » Virus like particles [VLP] 33
C12N2760/18531 » Uses of virus other than therapeutic or vaccine, e.g. disinfectant 0
C12N2760/18532 » Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent 12
C12N2760/18533 » Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory 5
C12N2760/18534 » Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein 477
C12N2760/18541 » Use of virus, viral particle or viral elements as a vector 4
C12N2760/18551 » Methods of production or purification of viral material 22
C12N2760/18561 » Methods of inactivation or attenuation 41
C12N2760/18571 » Demonstrated in vivo effect 80
C12N2760/18588 » For redistribution 0

Recent Application in this class:

20230167178

2023-06-01

Bispecific Molecules That Are Immunoreactive With Immune Effector Cells That Express An Activating Receptor And An Antigen Expressed By A Cell Infected By A Virus And Uses Thereof

20220363640

2022-11-17

ANTIVIRAL COMPOUNDS

20220362371

2022-11-17

HUMAN RESPIRATORY SYNCYTIAL VIRUS STRAIN AND ITS USE

20210403444

2021-12-30

HETEROCYCLIC DERIVATIVES FOR THE TREATMENT OF RSV

20210095021

2021-04-01

Bispecific molecules that are immunoreactive with immune effector cells that express an activating receptor and an antigen expressed by a cell infected by a virus and uses thereof

20190263754

2019-08-29

Antiviral compounds

20190144441

2019-05-16

Bicyclic fused pyrazole derivatives for the treatment of RSV

20190135770

2019-05-09

Heterocyclic derivatives for the treatment of RSV

20180320146

2018-11-08

Engineered respiratory syncytial viruses with control of cell-to-cell virus transmission for enhanced safety of live virus vaccines

#10

20180155423

2018-06-07

Bispecific molecules that are immunoreactive with immune effector cells that express an activating receptor and an antigen expressed by a cell infected by a virus and uses thereof

#11

20180065932

2018-03-08

ANTIVIRAL COMPOUNDS

#12

20160024476

2016-01-28

Anti-mycobacterial vaccines

#13

20160017038

2016-01-21

Bispecific molecules that are immunoreactive with immune effector cells that express an activating receptor and an antigen expressed by a cell infected by a virus and uses thereof

#14